Country
Contract Development & Manufacturing Organizations in India
The world's API powerhouse. Compare Indian CDMOs across API synthesis, oral solid dose, sterile fill-finish, and peptides — many FDA-inspected — by capability and site.
282 companies listed
Manufacturing sites in India
The Indian CDMO landscape
India is the engine of global small-molecule API manufacturing, with one of the largest concentrations of FDA-inspected drug facilities outside the United States. Indian CDMOs supply APIs and finished generics to nearly every major market and typically offer a 30–50% cost advantage over Western alternatives for chemical synthesis.
Capability has moved well beyond commodity APIs. Leading Indian CDMOs now run sterile fill-finish, complex injectables, peptide synthesis (riding the GLP-1 wave), and high-potency manufacturing. Manufacturing clusters around Hyderabad, Bengaluru, Gujarat, and the Mumbai–Pune corridor each carry distinct specializations.
Quality varies more than in Western markets, so due diligence is non-negotiable: facility inspection history, the relevant regulatory approvals for your target market, and quality-system maturity should drive selection. The upside — cost, scale, and a vast pool of FDA-inspected sites — is unmatched for the right program.
Companies (60)
Aarti Pharmalabs Limited
India
Actylis
India
Addii Biotech Pvt Ltd
India
Aizant Drug Research Solutions
India
Ajinomoto Bio-Pharma Services
India
Akriti Pharmaceuticals Pvt. Ltd.
India
Akums Drugs & Pharmaceuticals Ltd
India
AMN Life Science Pvt Ltd
India
Amster Microcell Pvt Ltd
India
Ananta Medicare Ltd
India
Anwita Drugs & Chemicals Pvt Ltd
India
Aparna Pharmaceuticals Pvt Ltd
India
Apotex (incl. Apotex Pharmachem)
India
A
AptarGroup Inc
India
Aragen Life Sciences Ltd.
India
Arkema
India
Arterex (medical device CM)
India
Atlas Life Sciences Private Limited
India
Aurigene Services
India
Aurobindo Pharma (incl. Eugia/Generis)
India
Axplora
India
AZIDUS LABORATORIES LIMITED
India
Bec Chemicals Pvt Ltd
India
Benzo Chem Industries Pvt Ltd
India
Biomatrix Healthcare Pvt. Ltd.
India
Biophore India Pharmaceuticals
India
Bioplus Life Sciences Pvt Ltd
India
Bliss GVS Pharma Ltd.
India
Bluejet Healthcare
India
Brawn Laboratories Ltd
India
C2 PHARMA
India
Cadchem Laboratories Ltd
India
Cadila Pharmaceuticals Ltd
India
C
Caplin Point Laboratories / Caplin Steriles
India
CARBOGEN AMCIS
India
C
Chaitanya Biologicals Pvt. Ltd.
India
C
CHEMCO INNOVATIVE CHEMIE PRIVATE LIMITED
India
Chemfield Cellulose
India
Chemical Resources (CHERESO)
India
Chemo Fab Industries LLP
India
Chempro Pharma
India
Chemveda Life Sciences India Pvt Ltd
India
Chemwerth
India
ChromoSep Technologies Private Limited
India
CILICANT
India
Cipla
India
Ciron Drugs & Pharmaceuticals Pvt Ltd
India
Clariant International AG
India
Cleanchem Laboratories LLP
India
Clearsynth
India
Clininvent Research Pvt Ltd
India
Cohance Lifesciences
India
Colorcon
India
Concord Biotech
India
Constantia Flexibles (Pharma)
India
Corel Pharma Chem
India
Corning Incorporated (Life Sciences & Pharmaceutical Technologies)
India
CRAMSN Research Park
India
CTX Life Sciences Pvt. Ltd.
India
CuraTeQ Biologics
India
Frequently Asked Questions
How many CDMOs are in India?+
CDMO Hub lists one of its largest country rosters in India — see the live count and ranked list above. The count is built from verified manufacturing sites, so it reflects real production footprint rather than headquarters.
Are Indian CDMOs FDA-approved?+
India has one of the highest concentrations of FDA-inspected drug-manufacturing facilities outside the US. Many Indian CDMOs hold FDA, EU GMP, and WHO prequalification. Approvals are facility- and product-specific, so always verify the inspection history of the specific site for your modality.
What is India strongest in — API or finished dose?+
India's historic strength is small-molecule API synthesis and oral-solid-dose generics, where it leads globally. It has rapidly built sterile fill-finish, complex injectables, and peptide capacity (notably for GLP-1 programs). For chemistry-driven and high-volume work, India is frequently the most cost-effective qualified option.
How does India compare to China for API manufacturing?+
Both are API powerhouses. India has a larger base of FDA-inspected facilities and a stronger English-language regulatory track record, while China leads in certain intermediates and scale. BIOSECURE-driven supply-chain diversification has made India a primary beneficiary of work shifting away from certain Chinese suppliers.
Find the right CDMO in India
Our AI Matchmaker analyzes your project requirements and matches you with qualified India manufacturing partners. Free for buyers.